Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases
Despite the advances in molecular biology and biochemistry, the prognosis of patients suffering from tumor diseases remains poor. The limited therapeutic success can be explained by the insufficient performance of the common chemotherapeutic drugs that lack the ability to specifically target tumor t...
Main Authors: | Walter Mier, Uwe Haberkorn, Mazen Jamous |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/18/3/3379 |
Similar Items
-
The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
by: Holis Abdul Holik, et al.
Published: (2022-05-01) -
Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
by: Cyprine Neba Funeh, et al.
Published: (2023-04-01) -
Analysis of Current Rules and Regulations for Preclinical Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2024-02-01) -
Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01) -
Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
by: G. E. Kodina, et al.
Published: (2022-10-01)